1. Detection of Fusion Genes to Determine Minimal Residual Disease in Leukemia Using Next-Generation Sequencing

    de Boer, E. N., Johansson, L. F., de Lange, K., Bosga-Brouwer, A. G., van den Berg, E., Sikkema-Raddatz, B. & van Diemen, C. C., Aug-2020, In : Clinical Chemistry. 66, 8, p. 1084-1092 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern

    Berger, G., Gerritsen, M., Yi, G., Koorenhof-Scheele, T. N., Kroeze, L. I., Stevens-Kroef, M., Yoshida, K., Shiraishi, Y., van den Berg, E., Schepers, H., Huls, G., Mulder, A. B., Ogawa, S., Martens, J. H. A., Jansen, J. H. & Vellenga, E., 22-Oct-2019, In : Blood. 3, 20, p. 3111-3122 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms

    Rack, K. A., van den Berg, E., Haferlach, C., Beverloo, H. B., Costa, D., Espinet, B., Foot, N., Jeffries, S., Martin, K., O'Connor, S., Schoumans, J., Talley, P., Telford, N., Stioui, S., Zemanova, Z. & Hastings, R. J., Aug-2019, In : Leukemia. 33, 8, p. 1851-1867 17 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

View all (99) »

ID: 136108